Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James George Robinson currently holds 4,782,065 shares of NYMOX PHARMACEUTICAL CORP (NYMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James George Robinson has been a net buyer of NYMX stock. They have purchased $6.0M and sold $0 worth of shares.
James George Robinson's most recent insider trade was on Apr 27, 2023, when they purchased 40,000 shares at $0.47 per share.
James George Robinson serves as Executive at NYMOX PHARMACEUTICAL CORP (NYMX). They have executed 380 insider transactions totaling $6.0M over their tenure at the company.
James George Robinson holds the position of Executive at NYMOX PHARMACEUTICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
James George Robinson has shown a buying trading pattern, with $6.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James George Robinson was on May 2, 2022, when they purchased $1.9M worth of NYMX shares. This transaction involved 1,151,515 shares at $1.65 per share.
James George Robinson currently owns 4,782,065 shares of NYMOX PHARMACEUTICAL CORP (NYMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James George Robinson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James George Robinson has 380 Form 4 filings on record as an insider at NYMOX PHARMACEUTICAL CORP.
Set alerts for James George Robinson and 40,000+ other insiders.